• FREE CE for GAPNA MembersFREE continuing education credit is available for the following session:

    "Sleep Disturbances in Dementia"

    (session captured at the GAPNA 2019 Annual Conference)

    For September/October 2020 - Get Your Free CNE Now!

  • Clinical Care OptionsNew for GAPNA members: Clinical Care Options

    GAPNA has partnered with a Clinical Care Options to offer an ongoing series of free CNE programs available to GAPNA members. "Vaccinations and Healthy Aging: Protecting Your Older Patients From Shingles" is the latest program offered.

    In this live webinar on September 30, 2020  at 3:00 PM, US Eastern, expert faculty expert faculty discuss how important it is to prevent shingles in older patients.

    Find out about it!

  • CoronaCoronavirus (COVID-19) Resources

    In an effort to support our members with the most updated information on COVID-19 we developed this resource page to easily access current CDC information and other resources to assist you professionally and personally.

    We will continue to update this page with more information as it becomes available and welcome your input as we navigate through this situation. As health care professionals it is our job to educate our patients and families on prevention and the what to do if someone is symptomatic.

    View resources


Lonhala Magnair

Study Results Argue Against Decisions About Screening Colonoscopy Based on Age Alone

The likely value of screening colonoscopy (SC) depends not just on the age and sex of the patient, but also on the number of co-morbidities a person has, according to a new study.

Initial guidelines for cancer screening, including SC to detect early-stage colorectal cancer (CRC), did not recommend an upper age limit for screening.

In 2008 the United States Preventive Services Task Force recommended against routine SC in patients 76-85 years old, and against any screening for CRC in patients older than 85.

The task force based its recommendations on diminishing benefit of SC with increasing age.

Researches in a new study found that taking into account the number of co-morbidities affected whether a patient was likely to benefit from SC, even after accounting for age.

For both men and women aged 85-94 with no co-morbidities, SC is estimated to save around 100 life-years per 100,000 patients screened (65 life-years for men, 111 life-years for women).

However, for men and women with at least three co-morbidities, there were no life-years saved for patients older than 74.

For more info, see Gross et al. (2011). Assessing the impact of screening colonoscopy on mortality in the Medicare population. Journal of General Internal Medicine, 26(12), 1441-1449.

Related Topic 1: 

GAPNA Newsletter Issue: